113 related articles for article (PubMed ID: 1826839)
1. Kinetic modelling of chloroquine uptake by malaria-infected erythrocytes. Assessment of the factors that may determine drug resistance.
Ginsburg H; Stein WD
Biochem Pharmacol; 1991 May; 41(10):1463-70. PubMed ID: 1826839
[TBL] [Abstract][Full Text] [Related]
2. Simulation of kinetic data on the influx and efflux of chloroquine by erythrocytes infected with Plasmodium falciparum. Evidence for a drug-importer in chloroquine-sensitive strains.
Ferrari V; Cutler DJ
Biochem Pharmacol; 1991 Dec; 42 Suppl():S167-79. PubMed ID: 1768274
[TBL] [Abstract][Full Text] [Related]
3. Vacuolar acidification and chloroquine sensitivity in Plasmodium falciparum.
Bray PG; Howells RE; Ward SA
Biochem Pharmacol; 1992 Mar; 43(6):1219-27. PubMed ID: 1562274
[TBL] [Abstract][Full Text] [Related]
4. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Meierjohann S; Walter RD; Müller S
Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
[TBL] [Abstract][Full Text] [Related]
5. Uptake of [3H]chloroquine by drug-sensitive and -resistant strains of the human malaria parasite Plasmodium falciparum.
Geary TG; Jensen JB; Ginsburg H
Biochem Pharmacol; 1986 Nov; 35(21):3805-12. PubMed ID: 3535803
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross.
Wellems TE; Panton LJ; Gluzman IY; do Rosario VE; Gwadz RW; Walker-Jonah A; Krogstad DJ
Nature; 1990 May; 345(6272):253-5. PubMed ID: 1970614
[TBL] [Abstract][Full Text] [Related]
7. Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum.
Krogstad DJ; Gluzman IY; Herwaldt BL; Schlesinger PH; Wellems TE
Biochem Pharmacol; 1992 Jan; 43(1):57-62. PubMed ID: 1531176
[TBL] [Abstract][Full Text] [Related]
8. Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect.
Martiney JA; Cerami A; Slater AF
J Biol Chem; 1995 Sep; 270(38):22393-8. PubMed ID: 7673225
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum.
Slater AF
Pharmacol Ther; 1993; 57(2-3):203-35. PubMed ID: 8361993
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine resistance-conferring mutations in pfcrt give rise to a chloroquine-associated H+ leak from the malaria parasite's digestive vacuole.
Lehane AM; Kirk K
Antimicrob Agents Chemother; 2008 Dec; 52(12):4374-80. PubMed ID: 18852275
[TBL] [Abstract][Full Text] [Related]
11. Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. A correlation of chloroquine sensitivity with energy-dependent drug accumulation.
Bray PG; Howells RE; Ritchie GY; Ward SA
Biochem Pharmacol; 1992 Oct; 44(7):1317-24. PubMed ID: 1417955
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake of a catechol iron chelator and chloroquine into Plasmodium falciparum infected erythrocytes.
Hammadi A; Ramiandrasoa F; Sinou V; Rogier C; Fusai T; Le Bras J; Parzy D; Kunesch G; Pradines B
Biochem Pharmacol; 2003 Apr; 65(8):1351-60. PubMed ID: 12694876
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of human malaria parasites to chloroquine is pH dependent.
Yayon A; Cabantchik ZI; Ginsburg H
Proc Natl Acad Sci U S A; 1985 May; 82(9):2784-8. PubMed ID: 3887411
[TBL] [Abstract][Full Text] [Related]
14. Kinetic modelling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro. Implications for mechanism of action of and resistance to the drug.
Geary TG; Divo AD; Jensen JB; Zangwill M; Ginsburg H
Biochem Pharmacol; 1990 Aug; 40(4):685-91. PubMed ID: 2201299
[TBL] [Abstract][Full Text] [Related]
15. Identification of a chloroquine importer in Plasmodium falciparum. Differences in import kinetics are genetically linked with the chloroquine-resistant phenotype.
Sanchez CP; Wünsch S; Lanzer M
J Biol Chem; 1997 Jan; 272(5):2652-8. PubMed ID: 9006900
[TBL] [Abstract][Full Text] [Related]
16. Malaria chemotherapy: resistance to quinoline containing drugs in Plasmodium falciparum.
Bray PG; Ward SA
FEMS Microbiol Lett; 1993 Oct; 113(1):1-7. PubMed ID: 8243975
[TBL] [Abstract][Full Text] [Related]
17. Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum.
Sanchez CP; Stein W; Lanzer M
Biochemistry; 2003 Aug; 42(31):9383-94. PubMed ID: 12899625
[TBL] [Abstract][Full Text] [Related]
18. Malagashanine potentiates chloroquine antimalarial activity in drug resistant Plasmodium malaria by modifying both its efflux and influx.
Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga S; Vial H
Mol Biochem Parasitol; 2006 Mar; 146(1):58-67. PubMed ID: 16313982
[TBL] [Abstract][Full Text] [Related]
19. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
Sante; 2008; 18(1):43-7. PubMed ID: 18684691
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine uptake and activity is determined by binding to ferriprotoporphyrin IX in Plasmodium falciparum.
Bray PG; Janneh O; Ward SA
Novartis Found Symp; 1999; 226():252-60; discussion 260-4. PubMed ID: 10645550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
